On Nov 3, Guangzhou's Baiyun district held a conference focused on its biomanufacturing industry, marking the beginning of a new phase of systematic development.

Guangzhou Baiyun Biomanufacturing Industry Launch Ceremony. [Photo/WeChat account: gz_baiyunfabu]

The district plans to build a comprehensive industrial ecosystem, featuring an innovation center, a pilot-scale production base, two commercialization platforms, a two-phase industrial park spanning over 1,000 mu (66.67 hectares), and a fund cluster totaling 100 billion yuan ($14.04 billion). This system will cover the entire industrial chain, from research and development to production, aiming to drive related industries to exceed 50 billion yuan in output by 2028 and become a nationally competitive leader in biomanufacturing.

"Baiyun's established cosmetic industry cluster offers an excellent foundation for biomanufacturing applications," said Liu Guohua, member of the Standing Committee of the CPC Baiyun District Committee. "We are positioning biomanufacturing as the central strategic focus to elevate the district's economic future."

Rendering of Phase I of the Biomanufacturing Industrial Park. [Photo/WeChat account: gz_baiyunfabu]

Rendering of Phase II of the Biomanufacturing Industrial Park. [Photo/WeChat account: gz_baiyunfabu]

The ecosystem is officially structured under an initiative, which is part of a three-year action plan spanning from 2026 to 2028. This structured effort aims to develop five leading enterprises, 30 high-tech firms and 10 specialized and sophisticated enterprises by the year 2028. 

The industrial park in Zhongluotan town will be developed in two phases: the 450-mu first phase will focus on sectors such as biomedicine and cosmetics, while the 900-mu second phase will expand into five major areas including biohealth and biomaterials. The fund cluster, led by State-owned enterprises and supported by multiple investment institutions, has raised 10 billion yuan in its first phase to support companies at all stages of growth.

"The fund covers the full lifecycle from startup to pre-IPO," said Zhang Yingjiao, deputy general manager of Baiyun Investment Group. "Whether a company needs seed funding, growth capital, or pre-listing financing, our ecosystem is designed to provide it."  

Home to about one-fifth of China's cosmetics manufacturers, Baiyun district boasts a strong industrial foundation, with the sector reaching 36.14 billion yuan in scale in 2024, while its biomedical industry has exceeded 31.1 billion yuan, anchored by giants like Guangzhou Pharmaceutical Group and Hutchison Whampoa. By combining funding support with key projects, the district aims to accelerate the commercialization of new technologies and position itself as an innovation hub for biomanufacturing in northern Guangzhou.